Rybrevant 350 mg/7 ml

Rybrevant 350 mg/7 ml is a medicine authorised by Swissmedic under authorisation number 68380. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 January 2022 and the authorisation is limited until 01 May 2029. ATC code L01FX18 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68380
  • ATC L01FX18
  • Biotechnological medicines
Authorisation data
Authorisation number68380
NameRybrevant 350 mg/7 ml
Full nameRybrevant 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderJanssen-Cilag AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX18
First authorisation20 January 2022
Authorisation validity01 May 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Rybrevant 350 mg/7 ml, Konzentrat zur Herstellung einer InfusionslösungA20 January 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX1807.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rybrevant 350 mg/7 ml authorised in Switzerland?

Yes. Rybrevant 350 mg/7 ml is authorised by Swissmedic under authorisation number 68380, data as of 01 September 2026. The authorisation is limited until 01 May 2029.

Which dispensing category does Rybrevant 350 mg/7 ml have?

Rybrevant 350 mg/7 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Rybrevant 350 mg/7 ml?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com